• Sylvia L Hargrave, Christina Hay, Jessamee Mellon, Elizabeth Mayhew, and Jerry Y Niederkorn.
• Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, Texas 75390-9057, USA.
• Invest. Ophthalmol. Vis. Sci. 2004 Apr 1; 45 (4): 1188-93.

PurposeTo determine whether the Th1 cytokine, interferon (IFN)-gamma, is necessary for corneal graft rejection.MethodsFull-thickness penetrating keratoplasties were performed in normal mice and in IFN-gamma knockout (KO) mice.ResultsSixty-four percent of the MHC-mismatched corneal allografts were rejected in IFN-gamma KO mice. By contrast, MHC-matched corneal allografts were rejected in 50% to 77% of the wild-type hosts, but were not rejected in any of the IFN-gamma KO mice or the wild-type mice treated with anti-IFN-gamma monoclonal antibody. Corneal graft rejection in IFN-gamma-deficient hosts was characterized by an eosinophilic infiltrate compared with a mononuclear inflammatory infiltrate in normal mice.ConclusionsIFN-gamma is not necessary for the rejection of MHC-mismatched corneal grafts. However, IFN-gamma and Th1 immune mechanisms are necessary for the rejection of MHC-matched corneal allografts that confront the host with foreign minor histocompatibility antigens. The immune response in atopic patients, as in IFN-gamma KO mice, is characterized by cross-regulation of Th1 cytokines, such as IFN-gamma. The present results indicate that MHC matching dramatically reduces the risk of corneal graft rejection when IFN-gamma is depressed or absent. Thus, MHC matching may reduce the risk of corneal graft rejection in patients with atopic keratoconus.

28 keywords...

hide…